Recent findings from the University of Sydney have uncovered a compelling associ...
Through its licensing deal with Eli Lilly, Sangamo Therapeutics received $18 mil...
The French biotech company Oncodesign Precision Medicine has been forced to tigh...
As research institutions throughout the United States grapple with increasing in...
RFK Jr supported the MMR vaccine’s efficacy in preventing measles, but also shar...
Following the launch of the first disease-modifying therapies for Alzheimer’s di...
Rhythm's Imcivree has shown benefit in a Phase III trial in patients with acquir...
China’s NMPA has granted approval for the marketing authorisation application of...
The CMS has opted not to move forward with a plan that would have extended Medic...
The European Commission (EC) has granted approval for AstraZeneca's Imfinzi plus...
Ethris has partnered Lonza for the development of room-temperature stable mRNA v...
US policy changes to withdraw from the WHO and cut USAID have had clinical reper...
The European Commission (EC) has granted approval for the extension of indicatio...
Eisai/Biogen’s Leqembi (lecanemab) was fully approved in the US in July 2023, an...
In a groundbreaking study, researchers from the University of Cambridge have rev...
A revolutionary new approach in the field of cancer surgery is emerging from Aus...
